Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors.

Sandip Pravin PatelTeresa Alonso-GordoaSusana BanerjeeDing WangJarushka NaidooNathan E StandiferDoug C PalmerLin-Yang ChengPanagiotis KourtesisMaria L AsciertoMayukh DasJennifer R DiamondMatthew D HellmannBenedito A Carneiro

Published in: Journal for immunotherapy of cancer (2024)

NCT02671435.

Keyphrases

open label
placebo controlled
double blind
clinical trial
randomized controlled trial